GLP-1 treatment prolongs digestion, helping to maintain your feeling of fullness for a longer period
These effects were substantial and help elucidate the remarkable glucose homeostasis abilities of tirzepatide observed in SURPASS-2 trial when compared with semaglutide (112)
Instead, speak with your provider about dose adjustment, medication for reflux, or alternative approaches
As research in this field continues to evolve, ongoing and future CVOTs will likely expand our knowledge of the cardiovascular benefits of GLP-1 receptor agonists, ultimately improving the care and outcomes of individuals with T2D and CVD
increasing the potential for falsified versions
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used mainly in treating type 2 diabetes, is the subject of increasing interest in scientific research due to its promising applications in treating various pathological conditions and those mentioned above